IBRX Other | IMMUNITYBIO, INC.

IMMUNITYBIO, INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

2025-03-03: Form 10-K; Item Smaller reporting company; As filed Yes.
2024-11-12: Form 10-Q; Item Smaller reporting company; As filed Yes.
2024-08-12: Form 10-Q; Item Smaller reporting company; As filed Yes.
2024-05-09: Form 10-Q; Item Smaller reporting company; As filed Yes.

Filed	Form	Item	As filed
2025-03-03	10-K	Smaller reporting company	Yes
2024-11-12	10-Q	Smaller reporting company	Yes
2024-08-12	10-Q	Smaller reporting company	Yes
2024-05-09	10-Q	Smaller reporting company	Yes
2024-03-19	10-K	Smaller reporting company	Yes
2024-03-19	10-K	Well-known seasoned issuer	No
2023-11-09	10-Q	Smaller reporting company	Yes
2023-08-08	10-Q	Smaller reporting company	Yes
2023-05-11	10-Q	Smaller reporting company	Yes
2023-03-01	10-K	Smaller reporting company	Yes
2023-03-01	10-K	Well-known seasoned issuer	No
2022-11-09	10-Q	Smaller reporting company	Yes
2022-03-01	10-K	Well-known seasoned issuer	No
2021-11-12	10-Q	Smaller reporting company	Yes
2021-08-12	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · IBRX · The Nasdaq
2021-08-12	10-Q	Smaller reporting company	Yes
2021-05-14	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · IBRX · The Nasdaq
2021-05-14	10-Q	Smaller reporting company	Yes
2021-03-04	10-K	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · NK · NASDAQ
2021-03-04	10-K	Smaller reporting company	Yes
2021-03-04	10-K	Well-known seasoned issuer	No
2020-11-09	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · NK · NASDAQ
2020-11-09	10-Q	Smaller reporting company	Yes
2020-11-09	10-Q	Emerging growth company	Yes
2020-08-07	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · NK · NASDAQ
2020-08-07	10-Q	Smaller reporting company	Yes
2020-08-07	10-Q	Emerging growth company	Yes
2020-05-11	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · NK · NASDAQ
2020-05-11	10-Q	Smaller reporting company	Yes
2020-05-11	10-Q	Emerging growth company	Yes
2020-03-25	10-K	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · NK · NASDAQ
2020-03-25	10-K	Smaller reporting company	Yes
2020-03-25	10-K	Emerging growth company	Yes
2020-03-25	10-K	Well-known seasoned issuer	No
2019-11-05	10-Q	Stock registered under Section 12(b)	Common Stock · NK · NASDAQ
2019-11-05	10-Q	Smaller reporting company	Yes
2019-11-05	10-Q	Emerging growth company	Yes
2019-08-06	10-Q	Stock registered under Section 12(b)	Common Stock · NK · NASDAQ
2019-08-06	10-Q	Smaller reporting company	Yes
2019-08-06	10-Q	Emerging growth company	Yes
2019-05-08	10-Q	Smaller reporting company	Yes
2019-05-08	10-Q	Emerging growth company	Yes
2019-03-13	10-K	Smaller reporting company	Yes
2019-03-13	10-K	Emerging growth company	Yes
2019-03-13	10-K	Well-known seasoned issuer	No
2018-11-07	10-Q	Smaller reporting company	Yes
2018-11-07	10-Q	Emerging growth company	Yes
2018-03-12	10-K	Well-known seasoned issuer	No
2017-03-15	10-K	Well-known seasoned issuer	No
2016-03-30	10-K	Well-known seasoned issuer	No

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Kymera Therapeutics, Inc. (KYMR)	United States	$9.631B	-31.69
Vaxcyte, Inc. (PCVX)	United States	$8.466B	-7.91
Krystal Biotech, Inc. (KRYS)	United States	$10.210B	45.56
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78
BIO-TECHNE Corp (TECH)	United States	$11.379B	74.68
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
CG Oncology, Inc. (CGON)	United States	$6.095B	-27.95
Scholar Rock Holding Corp (SRRK)	United States	$5.920B	-16.37
CRISPR Therapeutics AG (CRSP)		$5.390B	-11.68